Delivery Order SPE2DB20D3103-SPE2DB24FP0F4
- Not listed
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,516.82, is for the delivery of emtricitabine-tenofv 200-300mg pharmaceutical products. It is a Firm Fixed Price Delivery Order contract with a completion date of September 26, 2023. The contract is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award, valued at $1,844.33, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of EMTRICITABINE-TENOFV 200-300MG medical products. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,453.35, is for the delivery of emtricitabine-tenofovir 200-300 mg medications. The contract is a delivery order and has a firm fixed price pricing type, with a completion date of December 30, 2024. This award is not associated with a set-aside designation. AmerisourceBergen holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,267.59, is a Delivery Order for the procurement of Emtricitabine-Tenofovir 200-300 mg medication. It is a Firm Fixed Price contract with a completion date of March 7, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, from the Defense Logistics Agency (DLA). The contract, valued at $1,223.20, is a Firm Fixed Price Delivery Order with a performance period through January 23, 2025. The award is for the supply of emtricitabine-tenofovir 200-300mg medication. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,145.49 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300mg prescription medication. The contract is not designated as a set-aside and has a completion date of June 7, 2023. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The $3,385.31 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 mg medications, with a completion date of December 21, 2022. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The $1,929.72 firm fixed price delivery order is for the supply of Emtricitabine-Tenofovir 200-300 mg medications. This award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $3,588.81 firm fixed-price delivery order is for the supply of emtricitabine-tenofovir 200-300 milligram drug dosages. The contract has an ultimate completion date of July 23, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, to...
- This federal contract award with the ID SPE2DB20D3101|SPE2DB24FREH7 was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $1,045.68 firm fixed-price delivery order is for the provision of the pharmaceutical product 4564017020 - EMTRICITABINE-TENOFV 200-300MG UU 30S. This contract has a ceiling value of $1,045.68 and an ultimate completion date of March 20, 2024. The contract does not have a set-aside designation, indicating open competition....
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB24FP0F4Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,786.41, is a Delivery Order for the delivery of EMTRICITABINE-TENOFV 200-300MG medication. The contract has an ultimate completion date of June 3, 2024 and is a Firm Fixed Price contract. This contract award is not associated with a set-aside designation. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 5/31/24 |